Cargando…

Idiopathic Pleuroparenchymal Fibroelastosis

Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare form of idiopathic interstitial pneumonia. The disease is characterized by fibrosis of the pleura and subpleural lung parenchyma predominantly affecting the upper lobes. Various triggers have been proposed as inciting factors in the devel...

Descripción completa

Detalles Bibliográficos
Autores principales: Tavakolian, Kameron, Udongwo, Ndausung, Douedi, Steven, Odak, Mihir, Ilagan, Justin, Khan, Taimoor, Salam, Noor, Chaughtai, Saira, Asif, Arif
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119366/
https://www.ncbi.nlm.nih.gov/pubmed/35655629
http://dx.doi.org/10.14740/jmc3927
_version_ 1784710686874533888
author Tavakolian, Kameron
Udongwo, Ndausung
Douedi, Steven
Odak, Mihir
Ilagan, Justin
Khan, Taimoor
Salam, Noor
Chaughtai, Saira
Asif, Arif
author_facet Tavakolian, Kameron
Udongwo, Ndausung
Douedi, Steven
Odak, Mihir
Ilagan, Justin
Khan, Taimoor
Salam, Noor
Chaughtai, Saira
Asif, Arif
author_sort Tavakolian, Kameron
collection PubMed
description Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare form of idiopathic interstitial pneumonia. The disease is characterized by fibrosis of the pleura and subpleural lung parenchyma predominantly affecting the upper lobes. Various triggers have been proposed as inciting factors in the development of the disease. Diagnosis is made clinically in conjunction with radiographic findings and histopathology when available. There are no known effective treatment options and several cases of lung transplantation have been reported. We report a case of an 86-year-old female who presented to the emergency department with worsening dyspnea and hypoxia. She had a history of unexplained pneumomediastinum and a 20 - 25 pounds unintentional weight loss over 10 months. Computed tomography (CT) of the chest without contrast revealed radiographic evidence of IPPFE. Despite symptomatic management with antibiotics, diuretics, and steroids, her condition continued to deteriorate. Unfortunately, our patient was not a candidate for a lung transplant. She was transitioned to hospice care and succumbed to her disease. IPPFE is a rare disease with an unknown prevalence. It has a median survival rate of 2 years. Usually, there is an overlap with interstitial lung diseases, making it challenging to diagnose. There are only a few cases reported in the literature, and there are currently no guidelines available on the appropriate management of this debilitating disease. We recommend more cases be reported, and further research is done to establish better criteria for diagnosis and management.
format Online
Article
Text
id pubmed-9119366
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elmer Press
record_format MEDLINE/PubMed
spelling pubmed-91193662022-06-01 Idiopathic Pleuroparenchymal Fibroelastosis Tavakolian, Kameron Udongwo, Ndausung Douedi, Steven Odak, Mihir Ilagan, Justin Khan, Taimoor Salam, Noor Chaughtai, Saira Asif, Arif J Med Cases Case Report Idiopathic pleuroparenchymal fibroelastosis (IPPFE) is a rare form of idiopathic interstitial pneumonia. The disease is characterized by fibrosis of the pleura and subpleural lung parenchyma predominantly affecting the upper lobes. Various triggers have been proposed as inciting factors in the development of the disease. Diagnosis is made clinically in conjunction with radiographic findings and histopathology when available. There are no known effective treatment options and several cases of lung transplantation have been reported. We report a case of an 86-year-old female who presented to the emergency department with worsening dyspnea and hypoxia. She had a history of unexplained pneumomediastinum and a 20 - 25 pounds unintentional weight loss over 10 months. Computed tomography (CT) of the chest without contrast revealed radiographic evidence of IPPFE. Despite symptomatic management with antibiotics, diuretics, and steroids, her condition continued to deteriorate. Unfortunately, our patient was not a candidate for a lung transplant. She was transitioned to hospice care and succumbed to her disease. IPPFE is a rare disease with an unknown prevalence. It has a median survival rate of 2 years. Usually, there is an overlap with interstitial lung diseases, making it challenging to diagnose. There are only a few cases reported in the literature, and there are currently no guidelines available on the appropriate management of this debilitating disease. We recommend more cases be reported, and further research is done to establish better criteria for diagnosis and management. Elmer Press 2022-05 2022-05-07 /pmc/articles/PMC9119366/ /pubmed/35655629 http://dx.doi.org/10.14740/jmc3927 Text en Copyright 2022, Tavakolian et al. https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Non-Commercial 4.0 International License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Tavakolian, Kameron
Udongwo, Ndausung
Douedi, Steven
Odak, Mihir
Ilagan, Justin
Khan, Taimoor
Salam, Noor
Chaughtai, Saira
Asif, Arif
Idiopathic Pleuroparenchymal Fibroelastosis
title Idiopathic Pleuroparenchymal Fibroelastosis
title_full Idiopathic Pleuroparenchymal Fibroelastosis
title_fullStr Idiopathic Pleuroparenchymal Fibroelastosis
title_full_unstemmed Idiopathic Pleuroparenchymal Fibroelastosis
title_short Idiopathic Pleuroparenchymal Fibroelastosis
title_sort idiopathic pleuroparenchymal fibroelastosis
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9119366/
https://www.ncbi.nlm.nih.gov/pubmed/35655629
http://dx.doi.org/10.14740/jmc3927
work_keys_str_mv AT tavakoliankameron idiopathicpleuroparenchymalfibroelastosis
AT udongwondausung idiopathicpleuroparenchymalfibroelastosis
AT douedisteven idiopathicpleuroparenchymalfibroelastosis
AT odakmihir idiopathicpleuroparenchymalfibroelastosis
AT ilaganjustin idiopathicpleuroparenchymalfibroelastosis
AT khantaimoor idiopathicpleuroparenchymalfibroelastosis
AT salamnoor idiopathicpleuroparenchymalfibroelastosis
AT chaughtaisaira idiopathicpleuroparenchymalfibroelastosis
AT asifarif idiopathicpleuroparenchymalfibroelastosis